Remove 2002 Remove Data Remove Treatment
article thumbnail

Study: Marijuana a Useful Adjunct Treatment for Huntington Disease Symptoms

The Joint Blog

According to a new study published in the Journal of Pharmacy & Pharmaceutical Sciences, using marijuana as an adjunct treatment for Huntington disease (HD) is both effective and safe. Study selection, quality assessment and data extraction was performed by three reviewers.

article thumbnail

Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Cannabis Law Report

Dr. Greenshaw is a Fellow of the Royal Society of Arts; a Fellow of the Canadian College of Neuropsychopharmacology (CCNP), for which he served as President from 2000-2002; and a fellow of the Collegium Internationale Neuropsychopharmacologicum (CINP). “We would like to extend a warm welcome to Andy as he joins the team at Entheon.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can cannabis use during pregnancy contribute to low birth weight?

The Cannigma

in 2002 to 7% in 2017. The meta-analysis reviewed 32 studies containing data from approximately 5.5 Other research has found that children with neurodevelopmental and neuropsychiatric disorders may even benefit from treatment with exogenous cannabinoids such as CBD. An estimated 4.2% in certain states such as Maine.

article thumbnail

New American Medical Association Study Shows Cannabis Legalization Not Linked to Increased Psychosis

Veriheal

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

article thumbnail

All Cannabis Use Is Political

The Cannigma

Over the last 23 years, Americans for Safe Access (ASA) has been implementing a strategic plan that would allow medical cannabis to become a frontline treatment option for patients that is covered by insurance and readily available nationwide. and years of data proving the positive impacts that medical cannabis has on healthcare systems.

Policy 92
article thumbnail

Paper: Racial Capitalism and the African American Experience Entering the Cannabis Industry By Dr. Ayoka Nurse

Cannabis Law Report

The collection of data for the final study was through focused interviews with a snowball sample of eight participants who have experienced trying to enter the cannabis industry in Western City, California. Data were analyzed based on the central question, and three themes emerged. Central Research Question. London, UK: Pavilion Book.

Policy 105
article thumbnail

Alexander Hymowitz – Conant v. Walters

Cannabis Law Report

The Court writes, “The doctor-patient privilege reflects “the imperative need for confidence and trust” inherent in the doctor-patient relationship and recognizes that “a physician must know all that a patient can articulate in order to identify and to treat disease; barriers to full disclosure would impair diagnosis and treatment.”